Ionis Pharmaceuticals (IONS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
29.70 +0.13 (+0.44%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 29.70 unch (unch) 16:01 ET
for Fri, Apr 25th, 2025
Results
download Want to compare other data? Select Fields| Symbol | IONS | GRFS | SLNO | ||
| Company | Ionis Pharmaceuticals | Grifols S.A. ADR | Soleno Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 29.38 | 7.27 | 74.24 | ||
| High | 29.90 | 7.32 | 74.27 | ||
| Low | 28.87 | 7.15 | 72.78 | ||
| Last | 29.70 | 7.21 | 73.26 | ||
| Change | +0.13 | +0.03 | -0.97 | ||
| % Change | +0.44% | +0.42% | -1.31% | ||
| Volume | 1,015,500 | 1,008,700 | 776,300 | ||
| 20-Day Average Volume | 1,884,240 | 1,039,650 | 1,763,340 | ||
| Previous Close | 29.57 | 7.18 | 74.23 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 28.40 | 6.99 | 69.37 | ||
| 20-Day Raw Stochastic | 75.36% | 74.45% | 92.91% | ||
| 20-Day Relative Strength | 48.63% | 49.04% | 63.55% | ||
| Weighted Alpha | -32.22 | +2.70 | +57.39 | ||
| Today's Opinion | 88% Sell | 72% Sell | 100% Buy | ||
| Previous Opinion | 88% Sell | 72% Sell | 100% Buy | ||
| Last Month's Opinion | 80% Sell | 40% Sell | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.58% since 04/17/25 | +1.84% since 04/17/25 | +4.69% since 04/17/25 | ||
| Low | 27.90 on 04/21/25 | 6.86 on 04/21/25 | 68.30 on 04/21/25 | ||
| High | 30.12 on 04/23/25 | 7.35 on 04/23/25 | 74.50 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -7.96% since 03/25/25 | -4.50% since 03/25/25 | +46.37% since 03/25/25 | ||
| Low | 23.95 on 04/09/25 | 6.19 on 04/09/25 | 48.29 on 03/26/25 | ||
| High | 32.33 on 03/26/25 | 7.57 on 03/26/25 | 74.50 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -14.53% since 01/24/25 | -1.90% since 01/24/25 | +52.43% since 01/24/25 | ||
| Low | 23.95 on 04/09/25 | 6.19 on 04/09/25 | 43.00 on 03/11/25 | ||
| High | 35.31 on 01/27/25 | 8.81 on 03/06/25 | 74.50 on 04/23/25 | ||
| 6-Month | |||||
| %Chg | -24.22% since 10/25/24 | -17.41% since 10/25/24 | +33.39% since 10/25/24 | ||
| Low | 23.95 on 04/09/25 | 6.19 on 04/09/25 | 41.50 on 01/15/25 | ||
| High | 40.58 on 10/29/24 | 9.96 on 11/08/24 | 74.50 on 04/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,306,362 | 4,572,241 | 3,367,792 | ||
| Shares Outstanding, K | 158,965 | 687,555 | 49,908 | ||
| Annual Sales | 705,140,000 | 7,804,520,000 | 0 | ||
| Annual Net Income | -453,900,000 | 169,800,000 | -175,850,000 | ||
| Last Quarter Sales | 226,580,000 | 1,971,530,000 | 0 | ||
| Last Quarter Net Income | -104,350,000 | 56,840,000 | -55,980,000 | ||
| 60-Month Beta | 0.29 | 0.41 | -2.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.66 on 02/19/25 | 0.02 on 07/30/24 | -1.27 on 02/27/25 | ||
| Latest Earnings Date | 04/30/25 | 03/06/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | 0.370 on 06/03/21 | N/A | ||
| Next Ex-Dividends Date | N/A | 06/03/21 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||